山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
24期
4-6,9
,共4页
不孕症%种植窗期%子宫内膜%白血病抑制因子%体外受精胚胎移植
不孕癥%種植窗期%子宮內膜%白血病抑製因子%體外受精胚胎移植
불잉증%충식창기%자궁내막%백혈병억제인자%체외수정배태이식
infertility%window of implantation%endometrium%leukemia inhibitory factor%in vitro fertilization and embryo transfer
目的:分析种植窗期子宫内膜厚度、类型和宫腔冲洗液中白血病抑制因子( LIF)水平与体外受精胚胎移植( IVF-ET)妊娠结局的关系。方法选择行IVF或ICSI治疗的不孕患者105例,于IVF-ET前1个月经周期排卵后第7~9天,行阴道超声测量子宫内膜的厚度并分型,ELISA法测定宫腔冲洗液中的LIF。结果105例不孕症患者IVF-ET治疗后,妊娠64例、未妊娠41例,二者年龄、不孕时间、不孕类型差异无统计学意义;妊娠者种植窗期子宫内膜厚度为(11.89±1.63)mm,小于未妊娠者的(13.72±2.39)mm,P<0.05;子宫内膜厚度7~10、10~13、13~17 mm时,IVF-ET妊娠率分别为40.0%、72.7%、41.4%。本组A、B、C三种类型子宫内膜分别为50、36、19例,其妊娠率分别为70.0%、63.9%、31.6%;其中A型与B、C型比较,P均<0.05;B、C型比较,P>0.05。妊娠者宫腔冲洗液中LIF为(41.19±31.02)pg/mL,高于未妊娠者的(23.43±23.09)pg/mL,P<0.05。结论 IVF-ET前1个月经周期中经阴道超声测定子宫内膜的厚度和类型、检测宫腔冲洗液中LIF浓度对评价子宫内膜容受性、预测临床妊娠结局具有重要意义。
目的:分析種植窗期子宮內膜厚度、類型和宮腔遲洗液中白血病抑製因子( LIF)水平與體外受精胚胎移植( IVF-ET)妊娠結跼的關繫。方法選擇行IVF或ICSI治療的不孕患者105例,于IVF-ET前1箇月經週期排卵後第7~9天,行陰道超聲測量子宮內膜的厚度併分型,ELISA法測定宮腔遲洗液中的LIF。結果105例不孕癥患者IVF-ET治療後,妊娠64例、未妊娠41例,二者年齡、不孕時間、不孕類型差異無統計學意義;妊娠者種植窗期子宮內膜厚度為(11.89±1.63)mm,小于未妊娠者的(13.72±2.39)mm,P<0.05;子宮內膜厚度7~10、10~13、13~17 mm時,IVF-ET妊娠率分彆為40.0%、72.7%、41.4%。本組A、B、C三種類型子宮內膜分彆為50、36、19例,其妊娠率分彆為70.0%、63.9%、31.6%;其中A型與B、C型比較,P均<0.05;B、C型比較,P>0.05。妊娠者宮腔遲洗液中LIF為(41.19±31.02)pg/mL,高于未妊娠者的(23.43±23.09)pg/mL,P<0.05。結論 IVF-ET前1箇月經週期中經陰道超聲測定子宮內膜的厚度和類型、檢測宮腔遲洗液中LIF濃度對評價子宮內膜容受性、預測臨床妊娠結跼具有重要意義。
목적:분석충식창기자궁내막후도、류형화궁강충세액중백혈병억제인자( LIF)수평여체외수정배태이식( IVF-ET)임신결국적관계。방법선택행IVF혹ICSI치료적불잉환자105례,우IVF-ET전1개월경주기배란후제7~9천,행음도초성측양자궁내막적후도병분형,ELISA법측정궁강충세액중적LIF。결과105례불잉증환자IVF-ET치료후,임신64례、미임신41례,이자년령、불잉시간、불잉류형차이무통계학의의;임신자충식창기자궁내막후도위(11.89±1.63)mm,소우미임신자적(13.72±2.39)mm,P<0.05;자궁내막후도7~10、10~13、13~17 mm시,IVF-ET임신솔분별위40.0%、72.7%、41.4%。본조A、B、C삼충류형자궁내막분별위50、36、19례,기임신솔분별위70.0%、63.9%、31.6%;기중A형여B、C형비교,P균<0.05;B、C형비교,P>0.05。임신자궁강충세액중LIF위(41.19±31.02)pg/mL,고우미임신자적(23.43±23.09)pg/mL,P<0.05。결론 IVF-ET전1개월경주기중경음도초성측정자궁내막적후도화류형、검측궁강충세액중LIF농도대평개자궁내막용수성、예측림상임신결국구유중요의의。
Objective To explore the possible relationships of thickness and types of endometria in the window of im -plantation and leukemia inhibitory factor ( LIF) in uterine flushing fluid with the outcome of in vitro fertilization and embryo transfer ( IVF-ET) .Methods A total of 105 patients with infertility who underwent in vitro fertilization ( IVF) or intracy-toplasmic sperm injection ( ICSI) were examined in the window of implantation (7-9days after ovulation ) before the previ-ous cycle of IVF-ET.The thickness and sonographic appearance of endometrium was measured by transvaginal ultrasonogra -phy, and the concentrations of LIF in uterine flushing fluid by enzyme linked immunosorbent assay (ELISA).Results Sixty-four patients were successful in pregnancy and 41 patients failed after treatment .There was no difference in age , in-fertility time and infertility type between pregnant women and non-pregnant women .The endometrial thickness in the win-dow of implantation of pregnant women was significantly less than that of non -pregnant ones [(11.89 ±1.63) mm vs (13.72 ±2.39) mm](P<0.05).The endometrial thickness was divided into three groups:7-10mm, 10-13mm and 13-17mm, and the corresponding pregnant rates were 40%, 72.73%and 41.38%.The endometrial type of 50 women was A, of 36 women was B and of 19 women was C, and the corresponding pregnant rates were 70%, 63.9%and 31.6%.There was significant difference in the pregnant rate between type A and B , between type A and C (all P<0.05), but there was no significant difference between type B and C (P>0.025).The concentration of LIF in uterine flushing fluid of pregnancy group was higher than non-pregnancy group [(41.19 ±31.02) pg/mL vs (23.43 ±23.09) pg/mL](P<0.05).Conclu-sions It is important to examine the thickness and types of endometria by transvaginal ultrasonography and the concentra -tion of LIF in uterine flushing fluid in the previous cycle of IVF-ET for the assessment of endometrial receptivity and predic-tion of IVF-ET outcome.